National Human Genome Research Institute; Notice of Closed Meeting, 72067-72068 [2016-25214]
Download as PDF
<![CDATA[
sradovich on DSK3GMQ082PROD with NOTICES
Federal Register / Vol. 81, No. 202 / Wednesday, October 19, 2016 / Notices
Federal Officer, Chronic Fatigue
Syndrome Advisory Committee, Office
on Women’s Health, Office of the
Assistant Secretary for Health,
Department of Health and Human
Services, 200 Independence Avenue
SW., Room 712E, Washington, DC
20201. Nomination materials, including
attachments, may be submitted
electronically to cfsac@hhs.gov.
FOR FURTHER INFORMATION CONTACT: CDR
Gustavo Seinos, Designated Federal
Officer, Chronic Fatigue Syndrome
Advisory Committee, Office on
Women’s Health, Office of the Assistant
Secretary for Health, Department of
Health and Human Services, 200
Independence Ave. SW., Room 712E,
Washington, DC 20201. Inquiries may
also be made to cfsac@hhs.gov.
SUPPLEMENTARY INFORMATION: CFSAC
was established on September 5, 2002.
The purpose of the CFSAC is to provide
advice and recommendations to the
Secretary of HHS, through the ASH, on
issues related to ME/CFS. The CFSAC
advises and makes recommendations on
a broad range of topics including: (1)
Opportunities to improve knowledge
and research about the epidemiology,
etiologies, biomarkers and risk factors
for ME/CFS; (2) research on the
diagnosis, treatment, and management
of ME/CFS and potential impact of
treatment options; (3) strategies to
inform the public, health care
professionals, and the biomedical
academic and research communities
about ME/CFS advances; (4)
partnerships to improve the quality of
life of ME/CFS patients; and (5)
strategies to insure that input from ME/
CFS patients and caregivers is
incorporated into HHS policy and
research. The CFSAC charter is
available at: https://www.hhs.gov/
advcomcfs/charter/.
Management and support services for
Committee activities are provided by
staff from within the OASH. The ASH
provides direction and guidance for
services performed to support CFSAC
activities and operation.
Nominations: OASH is requesting
nominations to fill CFSAC positions
scheduled to be vacated at the end of
2016. The Committee composition
consists of seven scientists with
demonstrated expertise in biomedical
research applicable to ME/CFS, four
individuals with demonstrated expertise
in health care delivery, private health
care services, insurance, and three
patients/care givers of ME/CFS. The
vacant positions are in the biomedical
research category. Individuals selected
for appointment to the Committee will
serve as voting members and may be
VerDate Sep<11>2014
17:39 Oct 18, 2016
Jkt 241001
invited to serve terms of up to four
years.
CFSAC members are authorized to
receive a stipend for conducting
Committee related business, including
attending Committee meetings.
Committee members also are authorized
to receive per diem and reimbursement
for travel expenses incurred for
conducting Committee related business.
To qualify for consideration of
appointment to the Committee, an
individual must possess demonstrated
experience and knowledge in the
designated fields or disciplines, as well
as expert knowledge of the broad issues
and topics pertinent to ME/CFS.
Nomination materials should be
typewritten. If mailed, please submit
original documents. The nomination
materials should be submitted
(postmarked or received) no later than
5:00 p.m. EDT on the specified date.
The following information must be part
of the nomination package submitted for
each individual being nominated: (1) A
letter of nomination that clearly states
the name and affiliation of the nominee,
the basis for the nomination (i.e.,
specific attributes which qualify the
nominee for service in this capacity),
and a statement that the nominee is
willing to serve as a member of the
Committee; (2) the nominator’s name,
address, and daytime telephone
number; (3) the home and/or work
address, telephone number, and email
address of the individual being
nominated; and (4) a current copy of the
nominee’s curriculum vitae or resume,
which should not exceed 10 pages. An
individual may self-nominate. Federal
employees should not be nominated for
consideration of appointment to this
Committee. Nominations that do not
contain all of the above information will
not be considered.
Electronic submissions: Nomination
materials, including attachments, may
be submitted electronically to cfsac@
hhs.gov.
Regular, Express, or Overnight Mail:
Written documents may be submitted to
the following addressee only: CDR
Gustavo Seinos, MPH, Designated
Federal Officer, CFSAC, Office on
Women’s Health, Office of the Assistant
Secretary for Health, Department of
Health and Human Services, 200
Independence Ave. SW., Room 712E,
Washington, DC 20201.
Telephone and facsimile submissions
cannot be accepted.
Appointment to the Committee is
made by the Secretary of HHS. The
Department makes every effort to ensure
that the membership of federal advisory
committees is fairly balanced in terms of
points of view represented. Every effort
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
72067
is made to ensure that a broad
representation of geographic areas,
females, ethnic and minority groups,
and people with disabilities are given
consideration for membership on
federal advisory committees.
Appointment to this Committee shall be
made without discrimination on the
basis of age, race, ethnicity, gender,
sexual orientation, disability, and
cultural, religious, or socioeconomic
status. Nominations must state that the
nominee is willing to serve as a member
of CFSAC and appears to have no
conflict of interest that would preclude
membership. Candidates who are
selected for appointment to the
Committee are required to provide
detailed information concerning such
matters as financial holdings,
consultancies, and research grants or
contracts for an ethics analysis to be
conducted to identify potential conflicts
of interest.
Dated: October 14, 2016.
Nicole Greene,
Deputy Director, Office on Women’s Health.
[FR Doc. 2016–25307 Filed 10–18–16; 8:45 am]
BILLING CODE 4150–42–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the Board
of Scientific Counselors, National
Human Genome Research Institute.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in section
552b(c)(6), Title 5 U.S.C., as amended
for the review, discussion, and
evaluation of individual intramural
programs and projects conducted by the
NATIONAL HUMAN GENOME
RESEARCH INSTITUTE, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, National Human Genome
Research Institute.
Date: November 1–2, 2016.
Time: November 1, 2016, 6:00 p.m. to 9:30
p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
E:\FR\FM\19OCN1.SGM
19OCN1
72068
Federal Register / Vol. 81, No. 202 / Wednesday, October 19, 2016 / Notices
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, Annex Room, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Time: November 2, 2016, 8:00 a.m. to 6:30
p.m.
Agenda: To review and evaluate personal
qualifications and performance, and
competence of individual investigators.
Place: National Institutes of Health,
Building 50, Louis Stokes Laboratories, Room
1328, 50, South Drive, Bethesda, MD 20892.
Contact Person: Monica Berger, Executive
Secretary, Office of the Scientific Director,
National Human Genome Research Institute,
50 South Drive, Bldg. 50, Rm 5222, Bethesda,
MD 20892, 301–294–6873, bergerm@
mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: October 13, 2016.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–25214 Filed 10–18–16; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood
Institute; Notice of Closed Meeting
sradovich on DSK3GMQ082PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Heart, Lung, and
Blood Initial Review Group; NHLBI
Mentored Transition to Independence
Review Committee.
Date: November 5–6, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: Giuseppe Pintucci, Ph.D.,
Scientific Review Officer, Office of Scientific
17:39 Oct 18, 2016
Jkt 241001
Dated: October 13, 2016.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2016–25215 Filed 10–18–16; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Periodically, the Substance Abuse and
Mental Health Services Administration
(SAMHSA) will publish a summary of
information collection requests under
OMB review, in compliance with the
Paperwork Reduction Act (44 U.S.C.
Chapter 35). To request a copy of these
documents, call the SAMHSA Reports
Clearance Officer on (240) 276–1243.
BILLING CODE 4140–01–P
VerDate Sep<11>2014
Review/DERA, National Heart, Lung, and
Blood Institute, 6701 Rockledge Drive, Room
7192, Bethesda, MD 20892, 301–435–0287,
Pintuccig@nhlbi.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.233, National Center for
Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung
Diseases Research; 93.839, Blood Diseases
and Resources Research, National Institutes
of Health, HHS)
Project: SAMHSA Disaster Technical
Assistance Center Disaster Behavioral
Health Needs Assessment and Customer
Satisfaction Surveys (OMB No. 0930–
0325)—Revision
The Substance Abuse and Mental
Health Services Administration
(SAMHSA) is requesting approval for a
revision to the data collection associated
with the SAMHSA Disaster Technical
Assistance Center (DTAC) Disaster
Behavioral Health Needs Assessment
and Customer Satisfaction Surveys
(OMB No. 0930–0325), which expire on
May 31, 2017. Specifically, SAMHSA
DTAC plans to consolidate the Needs
Assessment Survey and Customer
Satisfaction Surveys into a single
instrument. The new revised
instrument, entitled SAMHSA DTAC
Customer Feedback Survey (CFS), under
this effort will also include a change in
administration to make it appropriate
for a single, streamlined survey.
The proposed data collection effort
will provide feedback on the overall
effectiveness of SAMHSA DTAC’s
services, ongoing needs at the national
PO 00000
Frm 00034
Fmt 4703
Sfmt 4703
level, and areas that require enhanced
technical assistance (TA) services.
SAMHSA DTAC will be responsible
for administering the data collection
instrument and analyzing the data.
SAMHSA DTAC will use data from the
instrument to inform current and future
TA activities and to ensure these
activities continue to align with state
and local needs.
A three-year clearance is being
requested. The SAMHSA DTAC CFS is
designed to allow the agency to collect
feedback on the overall effectiveness of
the services provided by SAMHSA
DTAC, as well as ongoing data regarding
disaster behavioral health (mental
health and substance use-related) needs
at the national level and areas that
require enhanced training and technical
assistance (TA) services. This is the
information that was previously
collected as part of the SAMHSA DTAC
Needs Assessment Survey (NAS) and
Customer Satisfaction Survey (CSS).
Data from this effort will continue to be
used to improve services to
jurisdictions, which will lead to (1)
better integration of disaster behavioral
health (DBH) needs with all-hazards
disaster preparedness and response, and
(2) improved outcomes at the state,
territory, tribal, and local levels with
less burden on participants. The new
Customer Feedback Survey integrates
and consolidates questions from the
previously utilized NAS and CSS,
which will reduce burden associated
with the number of instruments and
survey questions. SAMHSA DTAC will
continue to be responsible for survey
administration and analysis of the data
collected, which SAMHSA will use to
inform current and future training and
TA activities. Table 1 shows the
estimated burden associated with CFS
data collection activities and the
associated costs. It is anticipated that
the survey will be administered once
each year.
Participation in the Customer
Feedback Survey will be solicited from
all 50 states, the U.S. territories, and the
District of Columbia. The survey will be
administered to individuals who have
requested TA within the six months
prior to administration and those who
are subscribed to DTAC’s ecommunications, SAMHSA DTAC
Bulletin, or The Dialogue, at the time of
administration. Internet-based
technology will be used to collect data
via web-based survey for data entry and
management.
E:\FR\FM\19OCN1.SGM
19OCN1
]]>Agencies
[Federal Register Volume 81, Number 202 (Wednesday, October 19, 2016)]
[Notices]
[Pages 72067-72068]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-25214]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Human Genome Research Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
Board of Scientific Counselors, National Human Genome Research
Institute.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in section 552b(c)(6), Title 5
U.S.C., as amended for the review, discussion, and evaluation of
individual intramural programs and projects conducted by the NATIONAL
HUMAN GENOME RESEARCH INSTITUTE, including consideration of personnel
qualifications and performance, and the competence of individual
investigators, the disclosure of which would constitute a clearly
unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, National
Human Genome Research Institute.
Date: November 1-2, 2016.
Time: November 1, 2016, 6:00 p.m. to 9:30 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
[[Page 72068]]
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, Annex
Room, 7400 Wisconsin Avenue, Bethesda, MD 20814.
Time: November 2, 2016, 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate personal qualifications and
performance, and competence of individual investigators.
Place: National Institutes of Health, Building 50, Louis Stokes
Laboratories, Room 1328, 50, South Drive, Bethesda, MD 20892.
Contact Person: Monica Berger, Executive Secretary, Office of
the Scientific Director, National Human Genome Research Institute,
50 South Drive, Bldg. 50, Rm 5222, Bethesda, MD 20892, 301-294-6873,
bergerm@mail.nih.gov.
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human
Genome Research, National Institutes of Health, HHS)
Dated: October 13, 2016.
Sylvia L. Neal,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2016-25214 Filed 10-18-16; 8:45 am]
BILLING CODE 4140-01-P
